Dysentery vaccineAlternative Names: Diarrhoea vaccine
Latest Information Update: 24 Nov 2015
At a glance
- Originator Shanxi Kangbao Biological Product
- Developer Academy of Military Medical Sciences; Shanxi Kangbao Biological Product
- Class Antidiarrhoeals; Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Dysentery
Most Recent Events
- 24 Nov 2015 Phase-III development for Dysentery is ongoing in China